Table 1.
Comparison of baseline characteristics between controls and IS patient subtypes
| Control (n=164) | LAA (n=294) | Test Value | P value | SAO (n=248) | Test Value | P value | |
|---|---|---|---|---|---|---|---|
| Age | 62.74±14.02 | 71.53±11.55 | -6.286 | <0.001 | 68.62±11.40 | -4.226 | <0.001 |
| Gender | 81 (49.39%) | 183 (62.24%) | 7.125 | 0.008 | 143 (57.66%) | 2.722 | 0.099 |
| Smoking | 30 (18.29%) | 83 (28.23%) | 5.595 | 0.018 | 64 (25.81%) | 3.165 | 0.075 |
| TIA/Stroke | -- | 47 (15.99%) | -- | -- | 48 (19.35%) | -- | -- |
| HP | 76 (46.34%) | 249 (84.69%) | 75.146 | <0.001 | 207 (83.47%) | 63.267 | <0.001 |
| DM | 26 (15.85%) | 106 (36.05%) | 20.941 | <0.001 | 102 (41.13%) | 29.448 | <0.001 |
| CVD | 5 (3.05%) | 37 (12.59%) | 11.494 | 0.001 | 17 (6.85%) | 2.829 | 0.093 |
| SBP | 137.29±17.54 | 154.82±23.43 | -7.985 | <0.001 | 152.87±22.54 | -7.102 | <0.001 |
| DBP | 79.38±10.71 | 82.26±13.40 | -2.121 | <0.001 | 83.73±13.15 | 3.775 | <0.001 |
| FPG | 5.08 (4.73, 5.62) | 6.01 (5.17, 7.64) | -6.582 | <0.001 | 5.45 (4.83, 7.29) | -4.018 | <0.001 |
| LDL-C | 2.99±0.78 | 3.02±1.00 | 0.381 | 0.703 | 3.08±0.94 | 0.963 | 0.336 |
| eGFR | 113.37 (90.71, 131.37) | 106.15 (86.92, 128.55) | -1.888 | 0.059 | 112.26 (87.61, 128.29) | -1.145 | 0.157 |
| FA | 7.90 (6.00, 11.65) | 6.20 (4.60, 9.70) | -3.782 | <0.001 | 6.70 (4.30, 10.10) | -3.315 | 0.001 |
| VitB12 | 319.50 (223.00, 436.00) | 293.00 (203.00, 400.00) | -2.151 | 0.031 | 272.00 (191.00, 375.00) | -2.564 | 0.010 |
| tHCY | 14.85 (12.60, 16.80) | 17.0 (14.70, 20.40) | -5.642 | <0.001 | 17.30 (14.20, 21.50) | -5.169 | <0.001 |
HP, hypertension; DM, diabetes mellitus; CVD, cardiovascular disease; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; FA, folic acid; VitB12, vitamin B12; tHCY, total homocysteine.